S&P 500   5,027.30 (-0.48%)
DOW   37,701.92 (-0.26%)
QQQ   428.19 (-0.68%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,027.30 (-0.48%)
DOW   37,701.92 (-0.26%)
QQQ   428.19 (-0.68%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,027.30 (-0.48%)
DOW   37,701.92 (-0.26%)
QQQ   428.19 (-0.68%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,027.30 (-0.48%)
DOW   37,701.92 (-0.26%)
QQQ   428.19 (-0.68%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Doximity (DOCS) Stock Price, News & Analysis

$25.31
+0.25 (+1.00%)
(As of 12:04 PM ET)
Today's Range
$25.12
$25.57
50-Day Range
$25.06
$30.46
52-Week Range
$19.71
$37.10
Volume
371,247 shs
Average Volume
1.76 million shs
Market Capitalization
$4.72 billion
P/E Ratio
38.35
Dividend Yield
N/A
Price Target
$28.82

Doximity MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
14.0% Upside
$28.82 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.65mentions of Doximity in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$67,425 Sold Last Quarter
Proj. Earnings Growth
6.94%
From $0.72 to $0.77 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.19 out of 5 stars

Medical Sector

378th out of 930 stocks

Custom Computer Programming Services Industry

13th out of 23 stocks

DOCS stock logo

About Doximity Stock (NASDAQ:DOCS)

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

DOCS Stock Price History

DOCS Stock News Headlines

Analyzing TruBridge (NASDAQ:TBRG) and Doximity (NASDAQ:DOCS)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Doximity Inc - Ordinary Shares - Class A
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
6 Analysts Assess Doximity: What You Need To Know
DOCS Apr 2024 37.500 call
What 6 Analyst Ratings Have To Say About Doximity
Doximity Inc.
Forecasting The Future: 5 Analyst Projections For Doximity
DOCS Apr 2024 40.000 call
Doximity to Participate in Upcoming Investor Events
Doximity: Rating Upgrade To Buy As Outlook Turns Positive
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
4/17/2024
Next Earnings (Estimated)
5/21/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Custom computer programming services
Sub-Industry
N/A
Current Symbol
NASDAQ:DOCS
Fax
N/A
Employees
977
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.82
High Stock Price Target
$33.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+15.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
14 Analysts

Profitability

Net Income
$112.82 million
Pretax Margin
37.15%

Debt

Sales & Book Value

Annual Sales
$419.05 million
Cash Flow
$0.70 per share
Book Value
$4.98 per share

Miscellaneous

Free Float
113,052,000
Market Cap
$4.67 billion
Optionable
Not Optionable
Beta
1.17
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives


DOCS Stock Analysis - Frequently Asked Questions

Should I buy or sell Doximity stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 10 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings
or view top-rated stocks.

What is Doximity's stock price target for 2024?

14 Wall Street research analysts have issued twelve-month price targets for Doximity's shares. Their DOCS share price targets range from $23.00 to $33.00. On average, they predict the company's share price to reach $28.82 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for DOCS
or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2024?

Doximity's stock was trading at $28.04 at the start of the year. Since then, DOCS shares have decreased by 9.8% and is now trading at $25.29.
View the best growth stocks for 2024 here
.

When is Doximity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our DOCS earnings forecast
.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.06. The firm earned $135.28 million during the quarter, compared to the consensus estimate of $127.46 million. Doximity had a net margin of 29.39% and a trailing twelve-month return on equity of 16.08%.

What guidance has Doximity issued on next quarter's earnings?

Doximity issued an update on its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $473.3 million-$474.3 million, compared to the consensus revenue estimate of $467.3 million.

When did Doximity IPO?

Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Who are Doximity's major shareholders?

Doximity's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Capital LLC (0.04%), Apella Capital LLC (0.03%), RFG Advisory LLC (0.01%), NBC Securities Inc. (0.01%) and PFS Partners LLC (0.00%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends
.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOCS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners